$ISDR
ISSUER DIRECT CORP Stock $isdr

$isdr Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000165495421005233 Filed on May 06, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$4.980M	$4.016M
YoY Change	24.0%	-3.9%
Cost Of Revenue	$1.394M	$1.253M
YoY Change	11.25%	-3.76%
Gross Profit	$3.586M	$2.763M
YoY Change	29.79%	-3.96%
Gross Profit Margin	72.01%	68.8%
Selling, General & Admin	$2.478M	$2.112M
YoY Change	17.33%	-16.12%
% of Gross Profit	69.1%	76.44%
Research & Development	$249.0K	$194.0K
YoY Change	28.35%
% of Gross Profit	6.94%	7.02%
Depreciation & Amortization	$285.0K	$374.0K
YoY Change	-23.8%	-9.22%
% of Gross Profit	7.95%	13.54%
Operating Expenses	$2.879M	$2.515M
YoY Change	14.47%	-7.88%
Operating Profit	$707.0K	$248.0K
YoY Change	185.08%	68.71%
Interest Expense	$1.000K	$58.00K
YoY Change	-98.28%	-18.31%
% of Operating Profit	0.14%	23.39%
Other Income/Expense, Net
YoY Change
Pretax Income	$708.0K	$306.0K
YoY Change	131.37%	40.37%
Income Tax	$163.0K	$80.00K
% Of Pretax Income	23.02%	26.14%
Net Earnings	$545.0K	$226.0K
YoY Change	141.15%	10.24%
Net Earnings / Revenue	10.94%	5.63%
Basic Earnings Per Share	$0.15	$0.06
Diluted Earnings Per Share	$0.14	$0.06
COMMON SHARES
Basic Shares Outstanding	3.769K shares	3.788K shares
Diluted Shares Outstanding	3.817K shares	3.824K shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$20.55M	$16.20M
YoY Change	26.86%	8.26%
Cash & Equivalents	$20.55M	$16.20M
Short-Term Investments
Other Short-Term Assets	$383.0K	$241.0K
YoY Change	58.92%	1.26%
Inventory
Prepaid Expenses
Receivables	$2.966M	$2.172M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$23.90M	$18.61M
YoY Change	28.41%	5.99%
LONG-TERM ASSETS
Property, Plant & Equipment	$775.0K	$2.920M
YoY Change	-73.46%	2293.44%
Goodwill	$6.376M
YoY Change
Intangibles	$2.789M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$93.00K	$361.0K
YoY Change	-74.24%	36.74%
Total Long-Term Assets	$12.18M	$13.96M
YoY Change	-12.75%	11.2%
TOTAL ASSETS
Total Short-Term Assets	$23.90M	$18.61M
Total Long-Term Assets	$12.18M	$13.96M
Total Assets	$36.08M	$32.57M
YoY Change	10.76%	8.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$589.0K	$383.0K
YoY Change	53.79%	-38.72%
Accrued Expenses	$2.098M	$1.060M
YoY Change	97.92%	19.24%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$307.0K
YoY Change	-100.0%	-4.06%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.428M	$4.003M
YoY Change	35.6%	19.92%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$1.890M	$2.226M
YoY Change	-15.09%	2908.11%
Total Long-Term Liabilities	$1.890M	$2.226M
YoY Change	-15.09%	525.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.428M	$4.003M
Total Long-Term Liabilities	$1.890M	$2.226M
Total Liabilities	$7.580M	$6.366M
YoY Change	19.07%	54.78%
SHAREHOLDERS EQUITY
Retained Earnings	$6.488M
YoY Change
Common Stock	$4.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$28.50M	$26.21M
YoY Change
Total Liabilities & Shareholders Equity	$36.08M	$32.57M
YoY Change	10.76%	8.17%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$545.0K	$226.0K
YoY Change	141.15%	10.24%
Depreciation, Depletion And Amortization	$285.0K	$374.0K
YoY Change	-23.8%	-9.22%
Cash From Operating Activities	$1.269M	$602.0K
YoY Change	110.8%	12.31%
INVESTING ACTIVITIES
Capital Expenditures	$16.00K	$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$16.00K	$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$452.0K	$203.0K
YoY Change	122.66%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$253.0K	-$203.0K
YoY Change	24.63%
NET CHANGE
Cash From Operating Activities	$1.269M	$602.0K
Cash From Investing Activities	-$16.00K	$0.00
Cash From Financing Activities	-$253.0K	-$203.0K
Net Change In Cash	$1.000M	$399.0K
YoY Change	150.63%	-117.67%
FREE CASH FLOW
Cash From Operating Activities	$1.269M	$602.0K
Capital Expenditures	$16.00K	$0.00
Free Cash Flow	$1.253M	$602.0K
YoY Change	108.14%	11.07%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	657000	USD
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	383000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	23897000	USD
CY2021Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	394000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	775000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1756000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	93000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	6376000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2789000	USD
CY2021Q1	us-gaap	Assets Assets	36080000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	589000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2098000	USD
CY2021Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	358000	USD
CY2021Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2383000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5428000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	262000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1890000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	7580000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3770752	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	4000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	4000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-19000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	36080000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	258000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	197000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1971000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	6747000	USD
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22024000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22214000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-16000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6488000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	5943000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	28500000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	28142000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	248000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34889000	USD
CY2021Q1	us-gaap	Revenues Revenues	4980000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	58000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	708000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	306000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	163000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	80000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	545000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	1394000	USD
CY2020Q1	us-gaap	Cost Of Revenue CostOfRevenue	1253000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	3586000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	2763000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1404000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1216000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1074000	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	896000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	226000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	249000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	194000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	152000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	209000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	2879000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	2515000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	707000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	3000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	40000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	548000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	266000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	26100000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	45000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2020Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-203000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	40000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	226000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	26208000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	28142000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	63000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	199000	USD
CY2021Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-452000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	3000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	545000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	28500000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	545000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	226000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	285000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	374000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	28000	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	93000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-15000	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-42000	USD
CY2021Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	0	USD
CY2020Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	6000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	63000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	45000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-484000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-219000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-16000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	32000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	287000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	452000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	203000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-253000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-203000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1000000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	399000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	118000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	398000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-105000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	178000	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	74000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1269000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	602000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	199000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19556000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15766000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash EffectOfExchangeRateOnCash	-8000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash EffectOfExchangeRateOnCash	32000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20548000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16197000	USD
CY2021Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2020Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	10000	USD
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	93000	shares
CY2020Q4	us-gaap	Deferred Revenue DeferredRevenue	2212000	USD
CY2021Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	1075000	USD
CY2020Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	877000	USD
CY2021Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	2966000	USD
CY2020Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	3000000	USD
CY2021Q1	isdr	Libor Interest Rate LiborInterestRate	0.0175	pure
CY2020Q3	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.0186	pure
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	2514000	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	53000	USD
CY2020Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	44000	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	87000	USD
CY2021Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;">Financial instruments and related items which potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents and accounts receivables. The Company places its cash and temporary cash investments with credit quality institutions. Such cash balances are currently in excess of the FDIC insurance limit of $250,000. To reduce its risk associated with the failure of such financial institutions, each quarter the Company evaluates the rating of the financial institution in which it holds deposits. As of March 31, 2021, the total amount exceeding such limit was $19,123,000. The Company also had cash-on-hand of $108,000 in Europe and $886,000 in Canada as of March 31, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;">The Company believes it did not have any financial instruments that could have potentially subjected us to significant concentrations of credit risk for any relevant period.</p>
CY2021Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	USD
CY2021Q1	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	19123000	USD
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the allowance for doubtful accounts and the valuation of goodwill, intangible assets, deferred tax assets, and stock-based compensation. Actual results could differ from those estimates.</p>
CY2021Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	132000	USD
CY2020Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	170000	USD
CY2020Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	5000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	295000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	359000	USD
CY2020Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	87000	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	27000	USD
CY2020Q1	us-gaap	Variable Lease Cost VariableLeaseCost	32000	USD
CY2021Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	114000	USD
CY2020Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	119000	USD
CY2021Q1	isdr	Weighted Average Non Cancelable Lease Term WeightedAverageNonCancelableLeaseTerm	P6Y8M12D
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.038	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	60230	shares
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M24D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.89
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	58230	shares
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	41000	USD
CY2019Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1000000	USD
CY2020Q1	isdr	Increased In Repurchases Shares IncreasedInRepurchasesShares	2000000	USD
CY2021Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	179845	shares
CY2021Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	179845	shares
CY2021Q1	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	11.15
CY2021Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	179845	shares
CY2021Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	0	USD
CY2021Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	163000	USD
CY2019Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	80000	USD
CY2021Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	385000	USD
CY2021Q1	isdr	Lease Liability Non Current Portion LeaseLiabilityNonCurrentPortion	1890000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	369000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	379000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	389000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	812000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2603000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	-328000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2275000	USD
CY2021Q1	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000	pure
CY2020Q1	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000	pure

Files In Submission

Name	View Source	Status
0001654954-21-005233-index-headers.html	Edgar Link	pending
0001654954-21-005233-index.html	Edgar Link	pending
0001654954-21-005233.txt	Edgar Link	pending
0001654954-21-005233-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
isdr-20210331.xsd	Edgar Link	pending
isdr-20210331_cal.xml	Edgar Link	unprocessable
isdr-20210331_def.xml	Edgar Link	unprocessable
isdr-20210331_lab.xml	Edgar Link	unprocessable
isdr-20210331_pre.xml	Edgar Link	unprocessable
isdr_10q.htm	Edgar Link	pending
isdr_10qimg1.jpg	Edgar Link	pending
isdr_10qimg2.jpg	Edgar Link	pending
isdr_10q_htm.xml	Edgar Link	completed
isdr_ex311.htm	Edgar Link	pending
isdr_ex312.htm	Edgar Link	pending
isdr_ex321.htm	Edgar Link	pending
isdr_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ISDR
ISSUER DIRECT CORP Stock $isdr

2021 Q1 Form 10-Q Financial Statement

#000165495421005233 Filed on May 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ISDR ISSUER DIRECT CORP Stock $isdr

2021 Q1 Form 10-Q Financial Statement

#000165495421005233 Filed on May 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ISDR
ISSUER DIRECT CORP Stock $isdr